Skip to content
No picture yet

Descovy 25 mg / 200 mg – DIN 02454424

Descovy is Tenofovir Alafenamide Hemifumarate and Emtricitabine 25 mg / 200 mg (tablet), sold in Canada. It is used for HIV. It is supplied by Gilead Sciences Canada Inc. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.

Sold in Canada

Tenofovir Alafenamide Hemifumarate and Emtricitabine 25 mg / 200 mg

Brand
Descovy
Strength
Tenofovir Alafenamide Hemifumarate 25 mg / Emtricitabine 200 mg
Used for
HIV
Form
Tablet
Manufacturer
Gilead Sciences Canada Inc
Drug class
HIV medicine
Sold in
Canada
DIN
02454424

Source: Health Canada's Drug Product Database. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Emtricitabine and Tenofovir Alafenamide pills and guides

What is Emtricitabine and Tenofovir Alafenamide used for?

Emtricitabine and Tenofovir Alafenamide is used for HIV.

Medicine type
HIV medicine
Official uses from the US prescribing label

Treatment of HIV-1 Infection

DESCOVY is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and adolescent patients weighing at least 35 kg.

DESCOVY is indicated for the treatment of HIV-1 infection in pediatric patients weighing at least 14 kg to less than 35 kg in combination with other antiretroviral agents, including darunavir and cobicistat but not other protease inhibitors that require a CYP3A inhibitor.

HIV-1 Pre-Exposure Prophylaxis (PrEP)

DESCOVY is indicated in at-risk adults and adolescents weighing at least 35 kg for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection from sexual acquisition, excluding individuals at risk from receptive vaginal sex. Individuals must have a negative HIV-1 test immediately prior to initiating DESCOVY for HIV-1 PrEP.

Limitations of Use:

The indication does not include use of DESCOVY in individuals at risk of HIV-1 from receptive vaginal sex because effectiveness in this population has not been evaluated.

From the FDA-approved label on DailyMed (published Jul 29, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your medicine? Check the box

  • The box or bottle shows DIN 02454424.
  • It names Descovy, Tenofovir Alafenamide Hemifumarate and Emtricitabine 25 mg / 200 mg.
  • A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.

Sold in Canada as Descovy by Gilead Sciences Canada Inc.

In Canada: prescription only.

Ingredients

Active: Tenofovir Alafenamide (Tenofovir Alafenamide Hemifumarate), Emtricitabine

Other Emtricitabine and Tenofovir Alafenamide pills